On-line
Registration Kit
|
Agenda Overview
Environmental Impacts on the Genome and Epigenome: Mechanisms and Risks
EMS President: Jeffrey L. Schwartz
Program Chair: Catherine B. Klein
(information subject to change)
Friday | Saturday | Sunday | Monday | Tuesday | Wednesday
| Tuesday, October 18 |
| 7:00 AM–5:00 PM |
| |
Registration |
Inscription |
| 7:00 AM–5:00 PM |
| |
Speaker Ready Room Open |
Inscription 2 |
| 7:00 AM–8:30 AM |
| |
Breakfast Meetings |
|
| |
Breakfast Pick-Up for Meetings (Ticket Required—Breakfast Available at 6:45 AM) |
Net Café |
| |
Executive Board Meeting
|
Longueuil |
| |
Epigenetics
Special Interest Group
Leaders: Janet E. Baulch, University of Maryland, Baltimore and
Dana C. Dolinoy, University of Michigan |
Fontaine F |
| |
New Technologies
Special Interest Group
Leaders: Brinda Mahadevan, Abbott Laboratories and
Jennifer C. Sasaki, Alkermes, Inc. |
Fontaine G |
| 8:30 AM–9:30 AM |
| |
EMS Award Lecture (PL3)
Human Exposure
Unraveling the Mystery of a Global Environmental Disease
Chairperson: Catherine B. Klein, New York University School of Medicine
Lecturer: Arthur P. Grollman, Stony Brook University |
Outremont |
| 8:30 AM–12:00 NOON |
| |
Posters and Exhibits Open
Last Chance to View Posters and Exhibits! |
Fontaine B |
| 9:45 AM–12:15 PM |
| |
Symposium 9
Whole Genome Mutational Profiling of Environmentally Induced Cancer
Chairpersons: James C. Fuscoe, National Center For Toxicological Research, U.S. FDA and David A. Wheeler, Baylor College of Medicine
Supported in part by: Quaility and Regulatory, Global Occupational Toxicology |
Mont-Royal |
| 9:45 AM–10:10 AM |
Updates on Next-Generation Sequencing and Bioinformatics
David A. Wheeler, Baylor College of Medicine |
|
| 10:10 AM–10:35 AM |
Targeted Resequencing Using the PacBio RS Platform
John D. McPherson, Ontario Institute for Cancer Research |
|
| 10:35 AM–11:00 AM |
Paired-End Sequencing Reveals Characteristic Patterns of Structural Variations in Epithelial Cancer Genomes
Guillaume Bourque, McGill University |
|
| 11:00 AM–11:15 AM |
Break—In the Exhibit Hall |
|
| 11:15 AM–11:40 AM |
Landscape of Somatic Alterations in Cancer and Their Relationship to the Environment
Kristian Cibulskis, The Eli and Edythe L. Broad Institute |
|
| 11:40 AM–12:05 PM |
The Human SNP Site-Frequency-Spectrum
Richard A. Gibbs, Baylor College of Medicine |
|
| 12:05 PM–12:15 PM |
Discussion |
|
| 9:45 AM–12:15 PM |
| |
Symposium 10
Transcription and Genetic Instability
Chairpersons: Malcolm J. Lippert, Saint Michael’s College and Mats Ljungman, The University of Michigan
Organized by the DNA Repair and Mutagenic Mechanisms Special Interest Group |
Outremont |
| 9:45 AM–10:10 AM |
Role for Topoisomerase I in Transcription-Associated Mutagenesis
Malcolm J. Lippert, Saint Michael’s College |
|
| 10:10 AM–10:35 AM |
Transcription Impacts Genomic Stability via Multiple Mechanisms
Nayun Kim, Duke University Medical Center |
|
| 10:35 AM–11:00 AM |
Transcription Associated Recombination at Replication Forks in Mammalian Cells
Thomas Helleday, Gray Institute for Radiation Oncology and Biology |
|
| 11:00 AM–11:15 AM |
Break—In the Exhibit Hall |
|
| 11:15 AM–11:45 AM |
Transcription-Blockage by Lesions and Unusual DNA Structures
Philip C. Hanawalt, Stanford University |
|
| 11:45 AM–12:15 PM |
The Transcriptome and the DNA Repairome
Mats Ljungman, University of Michigan |
|
| 9:45 AM–12:15 PM |
| |
Symposium 11
Low Dose Mutagenesis and Carcinogenesis
Chairpersons: Errol Zeiger, Errol Zeiger Consulting and David M. DeMarini, U.S. Environmental Protection Agency
Supported in Part by: ILSI-HESI IVGT Project Committee |
Verdun |
| 9:45 AM–9:50 AM |
Low-Dose Mutagenesis and Carcinogenesis: Why Is This Issue Important
Errol Zeiger, Errol Zeiger Consulting |
|
| 9:50 AM–10:15 AM |
Low-Dose Mutagenicity Case Studies: MMS and MNU
Lynn H. Pottenger, The Dow Chemical Company |
|
| 10:15 AM–10:40 AM |
Low-Dose In Vivo Study of Acrylamide
Errol Zeiger, Errol Zeiger Consulting |
|
| 10:40 AM–11:00 AM |
Low-Dose Carcinogenicity Studies
David M. DeMarini, U.S. Environmental Protection Agency |
|
| 11:00 AM–11:15 AM |
Break—In the Exhibit Hall |
|
| 11:15 PM–11:40 PM |
Analysis of Low-Dose Mutagenicity Responses and the Applicability of Genotoxicity Tests for Carcinogen Potency Prediction
Lya Hernandez, National Institute for Public Health and the Environment |
|
| 11:40 PM–12:05 PM |
Dose Response Issues in the Regulation of Chemicals
Rita Schoeny, U.S. Environmental Protection Agency |
|
| 12:05 PM–12:15 PM |
Discussion |
|
| 12:15 PM–2:00 PM |
| |
Lunch on your own |
|
| 12:30 PM–1:45 PM |
| |
Lunch Meeting
(Advance Registration Required)
Women in the EMS Special Interest Group
Leaders: Janice M. Pluth, Lawrence Berkeley National Laboratory and
Glenda J. Gentile, University of Arizona
Lecturer: Geraldine L. Richmond, COACh Program, University of Oregon |
Fontaine F |
| 2:00 PM–3:15 PM |
| |
Symposium 12
Risks Associated with Inadvertent Exposures to Pharmaceutical and Prescription Drugs
Chairpersons: Brinda Mahadevan, Abbott Laboratories and Ainsley Weston, Centers for Disease Control and Prevention
Organized by the New Technologies Special Interest Group and the Applied Genetic Toxicology Special Interest Group |
Mont-Royal |
| 2:00 PM–2:15PM |
Inadvertent Exposures to Pharmaceutical Drugs: Overview
Ainsley Weston, National Institute for Occupational Safety and Health, CDC |
|
| 2:15 PM–2:35 PM |
Risk-Based Manufacture of Pharmaceutical Products
Brinda Mahadevan, Abbott Laboratories |
|
| 2:35 PM–2:55 PM |
Considerations for Risk Assessments of Genotoxic or Carcinogenic Impurities in Industry
John Nicolette, Abbott Laboratories |
|
| 2:55 PM–3:15 PM |
Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings
Thomas H. Connor, National Institute for Occupational Safety and Health, CDC |
|
| 2:00 PM–3:15 PM |
| |
Symposium 13
Using DNA Adducts in Risk Assessment: Approaches, Considerations, and Significance
Chairpersons: Lynn H. Pottenger, The Dow Chemical Company and
Annie Jarabek, National Center for Environmental Assessment, U.S. EPA
Primary Sponsor: ILSI-HESI DNA Adducts Project Committee |
Outremont |
| 2:00 PM–2:25 PM |
ILSI-HESI DNA Adducts Project Committee: Review of Case Study Outcomes: Tamoxifen, AFB1, and VCI
Lynn H. Pottenger, The Dow Chemical Company |
|
| 2:25 PM–2:40 PM |
Application of Decision Analytic Approach to Case Studies
Annie Jarabek, National Center for Environmental Assessment, U.S. EPA |
|
| 2:40 PM–3:00 PM |
Mutagenesis and Repair of O6- and N7-Alkylguanine Adducts
Robert Fuchs, Centre National de la Recherche Scientifique |
|
| 3:00 PM–3:15 PM |
Relevance of DNA Adduct Approaches to Regulatory Risk Assessment
Rita Schoeny, U.S. Environmental Protection Agency |
|
| 2:00 PM–4:45 PM |
| |
Platform Session 2
Mutagenesis and Carcinogenesis Mechanisms
Chairpersons: Ofelia A. Olivero, National Cancer Institute, NIH and Sandy K. Weiner, Johnson & Johnson
Presenting author is underlined. |
Verdun |
| 2:00 PM–2:15 PM |
Subchronic Oral Exposure to Benzo[a]Pyrene Induces Changes in Gene Expression Associated with Cellular Transformation in Mouse Lungs: A Toxicogenomics Study
Labib S¹, Williams A², Lemieux CL², White PA², Halappanavar S². ¹University of Ottawa, Ottawa, ON, Canada, ²Health Canada, Ottawa, ON, Canada |
|
| 2:15 PM–2:30 PM |
The Mouse Diversity Genotyping Array Profiles Tissue- and Genotype-Specific Mutations across the Mouse Genome
Eitutis ST, Wishart AE, Hill KA. The University of Western Ontario, London, ON, Canada |
|
| 2:30 PM–2:45 PM |
DNA Structure-Induced Genetic Instability in Mammals
Wang G, Vasquez K. University of Texas at Austin, Austin, TX, United States |
|
| 2:45 PM–3:00 PM |
Identification of Different Mechanisms of Non-Genotoxic Carcinogens Based on Gene Expression Profiling in Primary Mouse Hepatocytes
Schaap MM1,2, Jonker MJ³, Zwart PE¹, Wackers P³, van de Water B4, Breit TM³, Schoonen WG5, Polman J5, van Steeg H1,2, Luijten M¹. ¹National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands, ²Department of Toxicogenetics, Leiden University Medical Center, Leiden, Netherlands, ³MicroArray Department and Integrative Bioinformatics Unit, University of Amsterdam, Amsterdam, Netherlands, 4Leiden Amsterdam Center for Drug Research (LACDR), Leiden University, Leiden, The Netherlands, 5Merck Sharp & Dome, Oss, Netherlands |
|
| 3:00 PM–3:15 PM |
Tissue Specificity of Aristolochic Acid-Induced Carcinogenesis Examined by ACB-PCR Quantification of H-Ras Codon 61 CTA Mutant Fraction
Wang Y¹, McKim KL¹, Myers MB¹, Arlt VM², Parsons BL¹. ¹National Center for Toxicological Research, U.S. FDA, Jefferson, AR, United States, ²Institute of Cancer Research, Sutton, Surrey, United Kingdom |
|
| 3:15 PM–3:30 PM |
Break |
|
| 3:30 PM–3:45 PM |
Toxicogenomic Late Effects of Antineoplastic Therapies for Lymphomas
Marcondes JPC¹, Torres BP¹, Niéro-Melo L¹, Gaiolla RD¹, Luisi FAV², Salvadori DMF¹. ¹São Paulo State University, Botucatu, SP, Brazil, ²São Paulo Federal University, São Paulo, SP, Brazil |
|
| 3:45 PM–4:00 PM |
Functional Studies of Single-Nucleotide Polymorphic Variants of Human Glutathione Transferase T1-1 Involving Residues in the Dimer Interface
Josephy PD¹, Pan D¹, Ianni MD¹, Mannervik B2,3. ¹University of Guelph, Guelph, Canada, ²Uppsala University, Uppsala, Sweden, ³Stockholm University, Stockholm, Sweden |
|
| 4:00 PM–4:15 PM |
Analyzing the Relationship between Radiation-Induced Phospho-Protein Signaling and Surrogate Cancer Endpoints Using Novel Flow-Based Assays
Whalen MK¹, Sridharan DM¹, Wilson W¹, Chapell L², Cucinotta FA², Pluth JM¹. ¹Lawrence Berkeley National Laboratory, Berkeley, CA, United States, ²Lyndon B. Johnson Space Center, Houston, TX, United States |
|
| 4:15 PM–4:30 PM |
Lethal Mutagenesis of HIV and Cancer Cells by Nucleoside Analogs
Fox EJ¹, Shen JC¹, Prindle MJ¹, Harris KS4, Mullins JI³, Essigmann JM5, Loeb LA1,2. ¹Department of Pathology, University of Washington, Seattle, WA, United States, ²Department of Biochemistry, University of Washington, Seattle, WA, United States, ³Department of Microbiology, University of Washington, Seattle, WA, United States, 4Koronis Pharmaceuticals, Seattle, WA, United States, 5Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, United State |
|
| 4:30 PM–4:45 PM |
Role of the Circadian Clock in UV-Induced Skin Carcinogenesis
Gaddameedhi S, Selby CP, Sancar A. University of North Carolina, Chapel Hill, NC, United States |
|
| 3:15 PM–3:30 PM |
| |
Break |
|
| 3:30 PM–4:45 PM |
| |
Symposium 14
Environmental Oil Contamination: Effects on Marine Life and Human Life
Chairpersons: Christopher M. Somers, University of Regina and Miriam C. Poirier, National Cancer Institute, NIH
Organized by the Molecular Epidemiology Special Interest Group and the Environmental Genetic Toxicology Special Interest Group |
Mont-Royal |
| 3:30 PM–3:45 PM |
Voyage 2 of the Odyssey: The Impact of the Oil Crisis on Health Using Whales As an Indicator Species
John Wise, University of Southern Maine |
|
| 3:45 PM–4:00 PM |
NIOSH Health Hazard Evaluation Conducted in the Aftermath of the Deepwater Horizon (DWH) Disaster
Ainsley Weston, National Institute for Occupational Safety and Health, CDC |
|
| 4:00 PM–4:15 PM |
Are Seafood Safety Considerations Adequate to Prevent Chronic Health Effects of the Deep Water Horizon Oil Spill on Coastal Louisiana Residents?
Patricia L. Williams, University of New Orleans |
|
| 4:15 PM–4:30 PM |
Overview of the Toxicity of the Oil Dispersant Corexit
David M. DeMarini, U.S. Environmental Protection Agency |
|
| 4:30 PM–4:45 PM |
Panel Discussion |
|
| 3:30 PM–4:45 PM |
| |
Symposium 15
Intestinal Microbiota: A Key Player in Obesity, Genomic Instability, and Lymphoma
Chairperson: Robert H. Schiestl, UCLA School of Medicine and Public Health |
Outremont |
| 3:30 PM–4:00 PM |
Intestinal Microbiota Affect Genetic Instability, Longevity and Lymphoma Latency in Atm-/- Mice
Robert H. Schiestl, UCLA School of Medicine and Public Health |
|
| 4:00 PM–4:15 PM |
The Intestinal Host-Microbial Ecosystem: A Systems Biology Approach to Inflammation and Cancer Risk
Jonathan Braun, David Geffen School of Medicine at UCLA |
|
| 4:15 PM–4:30 PM |
Intestinal Microbiota Involved in Rheumatoid Arthritis
Jose U. Scher, New York University Langone Medical Center |
|
| 4:30 PM–4:45 PM |
Discussion |
|
| 5:30 PM–6:50 PM |
| |
Public Lecture (L1)
Cancer in Beluga Whales from the St. Lawrence Estuary, Québec, Canada: A Case of “One Health, One Medicine”
Lecturer: Daniel Martineau, University of Montréal |
Outremont |
|
|